These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7134029)

  • 1. Central antinociceptive effects of lysine-vasopressin and an analogue.
    Kordower JH; Sikorszky V; Bodnar RJ
    Peptides; 1982; 3(4):613-7. PubMed ID: 7134029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin analgesia: specificity of action and non-opioid effects.
    Kordower JH; Bodnar RJ
    Peptides; 1984; 5(4):747-56. PubMed ID: 6494025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of morphine analgesia by intracerebroventricular naloxonazine.
    Simone DA; Bodnar RJ; Portzline T; Pasternak GW
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1721-7. PubMed ID: 3016762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EEG effects of subcutaneous and intracerebroventricular injections of arginine vasopressin in the rat.
    Ehlers CL; Reed TK; Wang M; Lebrun CJ; Koob GF
    Psychopharmacology (Berl); 1985; 87(4):430-3. PubMed ID: 3936102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the putative 5-HT1A receptor agonist 8-OH-2-(di-n-propylamino)tetralin on nociceptive sensitivity in mice.
    Fasmer OB; Berge OG; Post C; Hole K
    Pharmacol Biochem Behav; 1986 Oct; 25(4):883-8. PubMed ID: 2947249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of intraventricular and intracisternal administration of vasopressin on blood pressure in rats.
    Günther O; Kovács GL; Szabó G; Telegdy G
    Peptides; 1986; 7(3):539-40. PubMed ID: 3774590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vasopressin-glycine and vasopressin-glycine-lysine-arginine on renal function in the rat.
    Lote CJ; McVicar AJ; Smyth DG
    J Endocrinol; 1986 Feb; 108(2):255-60. PubMed ID: 3950530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect on brain 5-HT of central lysine-vasopressin administration into different cerebral ventricular compartments depends on the site of injection.
    Günther O; Szabó G; Kovács GL; Telegdy G
    Neuropeptides; 1986 Apr; 7(3):241-5. PubMed ID: 3713994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin-induced antinociception: an investigation into its physiological and hormonal basis.
    Berson BS; Berntson GG; Zipf W; Torello MW; Kirk WT
    Endocrinology; 1983 Jul; 113(1):337-43. PubMed ID: 6861706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine-vasopressin and lysine-vasopressin have different effects on spontaneous behaviour of rats.
    Tendis S; Klingberg F; Schaeker W
    Biomed Biochim Acta; 1987; 46(10):719-25. PubMed ID: 3446200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of vasopressin analgesia in rats treated neonatally with monosodium glutamate.
    Bodnar RJ; Truesdell LS; Nilaver G
    Peptides; 1985; 6(4):621-6. PubMed ID: 4070021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICV-CRH potently affects behavior without altering antinociceptive responding.
    Sherman JE; Kalin NH
    Life Sci; 1986 Aug; 39(5):433-41. PubMed ID: 3488483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of vasopressin analgesia following lesions placed in the rat hypothalamic paraventricular nucleus.
    Bodnar RJ; Truesdell LS; Haldar J; Aral IA; Kordower JH; Nilaver G
    Peptides; 1986; 7(1):111-7. PubMed ID: 3714529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse.
    Suh HW; Kim YH; Choi YS; Song DK
    Peptides; 1995; 16(7):1229-34. PubMed ID: 8545243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraventricular administration of neurohypophyseal hormones interferes with the development of tolerance to ethanol.
    Szabó G; Kovács GL; Telegdy G
    Acta Physiol Hung; 1989; 73(1):97-103. PubMed ID: 2711843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductions in pain thresholds and morphine analgesia following intracerebroventricular parachlorophenylalanine.
    Bodnar RJ; Kordower JH; Reches A; Wallace MM; Fahn S
    Pharmacol Biochem Behav; 1984 Jul; 21(1):79-84. PubMed ID: 6235525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin effects on isolated non-pregnant myometrium and uterine arteries and their inhibition by deamino-ethyl-lysine-vasopressin and deamino-ethyl-oxytocin.
    Akerlund M; Kostrzewska A; Laudănski T; Melin P; Vilhardt H
    Br J Obstet Gynaecol; 1983 Aug; 90(8):732-8. PubMed ID: 6882706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of intracerebroventricularly and intracisternally administered vasopressin on the hypothalamic self-stimulation rate of the rat.
    Günther O; Schwarzberg H
    Neuropeptides; 1987; 10(4):361-7. PubMed ID: 3431670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrogenic doses of intracerebroventricular interleukin-1 did not induce analgesia in the rat hot-plate or cold-water tail-flick tests.
    Adams JU; Bussiere JL; Geller EB; Adler MW
    Life Sci; 1993; 53(18):1401-9. PubMed ID: 8231628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intraperitoneally injected lysine vasopressin on noradrenaline turnover in certain brain regions of the rat.
    Szadowska A; Szmigielska H; Szmigielski A
    Acta Physiol Pol; 1982; 33(5-6):447-53. PubMed ID: 6821183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.